VTRS Q3 2017 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

Q3 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$3.0B-2.3% YoY

Gross Profit

$1.2B39.4% margin

Operating Income

$317M10.6% margin

Net Income

$88M3.0% margin

EPS (Diluted)

$0.16

QoQ Revenue Growth

+0.8%

Cash Flow

Operating Cash Flow

$549M

Free Cash Flow

$502M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$35.8B

Total Liabilities

$22.5B

Stockholders' Equity

$13.3B

Cash & Equivalents

$615M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.0B	$3.1B	-2.3%
Gross Profit	$1.2B	$1.3B	-8.2%
Operating Income	$317M	-$131M	+342.2%
Net Income	$88M	-$120M	+173.7%